OsimertinibTreatment failure secondary to drug resistance due to EGFR triple mutation: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1721卷 / 1期

关键词：

D O I：

10.1007/s40278-018-52264-9

中图分类号：

学科分类号：

摘要：

引用

页码：227 / 227

共 50 条

[41] AlectinibAcquired drug resistance with secondary ALK mutations: case report
Reactions Weekly, 2019, 1738 (1) : 14 - 14
[42] Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient with EGFR TKI Drug Resistance
Xu, S.
Liu, X.
Liu, R.
Shi, T.
Li, X.
Zhong, D.
Wang, Y.
Chen, G.
Chen, J.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2201 - S2201
[43] Asunaprevir/daclatasvirTreatment failure secondary to drug resistance: 7 case reports
Reactions Weekly, 2018, 1707 (1) : 55 - 55
[44] Ciprofloxacin/doxycycline/gentamicinTreatment failure and drug resistance: case report
Reactions Weekly, 2025, 2053 (1) : 94 - 94
[45] Fusidic acid/rifampicinRifampicin resistance due to rpoB gene mutation and fusidic acid resistance due to fusA gene mutation: case report
Reactions Weekly, 2016, 1622 (1) : 100 - 100
[46] Tumor Heterogeneity and Drug Resistance Mutations Using ctDNA in Metastatic EGFR Mutation-Positive Lung Adenocarcinoma: A Case Report
Sun, Jinghua
Sun, Ge
Lu, KeMou
Xu, Lingling
Qu, XiaoNa
Cheng, Ye
Pan, Evenki
Yang, Peng
Wu, Tingting
Zhang, Yang
He, HongMei
ONCOTARGETS AND THERAPY, 2022, 15 : 919 - 923
[47] DolutegravirEmergence of mutations, drug resistance and virologic failure: case report
Reactions Weekly, 2018, 1731 (1) : 101 - 101
[48] DolutegravirEmergence of mutations, drug resistance and virologic failure: case report
Reactions Weekly, 2019, 1748 (1) : 186 - 186
[49] Hydralazine/nitroglycerinTreatment failure following drug resistance : case report
Reactions Weekly, 2021, 1877 (1) : 181 - 181
[50] CotrimoxazoleDevelopment of drug resistance leading to treatment failure: case report
Reactions Weekly, 2022, 1920 (1) : 173 - 173

← 1 2 3 4 5 →